ZOLEDRONIC ACID SEACROSS 4 MG5 ML

Страна: Ізраїль

мова: англійська

Джерело: Ministry of Health

Активний інгредієнт:

ZOLEDRONIC ACID AS MONOHYDRATE

Доступна з:

A.L. MEDI-MARKET LTD.

Код атс:

M05BA08

Фармацевтична форма:

CONCENTRATE FOR SOLUTION FOR INFUSION

Склад:

ZOLEDRONIC ACID AS MONOHYDRATE 0.8 MG / 1 ML

Адміністрація маршрут:

I.V

Тип рецепту:

Required

Виробник:

SICHUAN HUIYU PHARMACEUTICAL CO., LTD., CHINA

Терапевтична области:

ZOLEDRONIC ACID

Терапевтичні свідчення:

Treatment of hypercalcaemia of malignancy (HCM). Treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy.Prostate cancer should have progressed after treatment with at least one hormonal therapy.

Дата Авторизація:

2022-06-29

інформаційний буклет

Page 1 of 5
_ _
Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) - 1986
The dispensing of this medicine requires a doctor’s prescription
Zoledronic Acid Seacross 4 mg/5 ml
Concentrate for solution for infusion
Active ingredient:
One 5 ml vial contains 4 mg zoledronic acid.
Inactive ingredients and allergens: see section 2 under 'Important
information about some of this medicine's
ingredients', and section 6 'Additional Information'.
Read the entire leaflet carefully before using this medicine. This
leaflet contains concise information about this
medicine. If you have further questions, refer to your doctor or
pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may harm them, even if it seems
to you that their illness is similar to yours.
1. What is this medicine intended for?
Zoledronic Acid Seacross is used to:
−
treat patients with multiple myeloma and patients with documented bone
metastases from solid tumours (where
cancer spreads from the primary site to the bone), together with
standard anticancer therapy.
−
For prostate cancer, treatment is given if there is progression after
at least one hormonal treatment.
−
reduce the amount of calcium in the blood in patients where the level
is too high due to presence of a tumour.
Therapeutic group:
Bisphosphonates
The active substance in Zoledronic Acid Seacross is zoledronic acid,
which belongs to a group of substances called
bisphosphonates. Zoledronic acid works by attaching itself to the bone
and slowing down the rate of bone change.
2. Before using this medicine
Carefully follow all the instructions given to you by the doctor.
Do not use this medicine if:
Special warnings about using this medicine
Before treatment with the medicine, tell your doctor if:
−
you have or have had a kidney problem.
−
you have or have had pain, swelling or numbness of the jaw, a feeling
of heaviness in the jaw or loosening of a
tooth. Your doctor may recommend a dental examination before you sta